Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer.
Lazar V, Rubin E, Depil S, Pawitan Y, Martini JF, Gomez-Navarro J, Yver A, Kan Z, Dry JR, Kehren J, Validire P, Rodon J, Vielh P, Ducreux M, Galbraith S, Lehnert M, Onn A, Berger R, Pierotti MA, Porgador A, Pramesh CS, Ye DW, Carvalho AL, Batist G, Le Chevalier T, Morice P, Besse B, Vassal G, Mortlock A, Hansson J, Berindan-Neagoe I, Dann R, Haspel J, Irimie A, Laderman S, Nechushtan H, Al Omari AS, Haywood T, Bresson C, Soo KC, Osman I, Mata H, Lee JJ, Jhaveri K, Meurice G, Palmer G, Lacroix L, Koscielny S, Eterovic KA, Blay JY, Buller R, Eggermont A, Schilsky RL, Mendelsohn J, Soria JC, Rothenberg M, Scoazec JY, Hong WK, Kurzrock R. Lazar V, et al. Among authors: onn a. Oncotarget. 2015 Jun 10;6(16):14139-52. doi: 10.18632/oncotarget.3741. Oncotarget. 2015. PMID: 25944621 Free PMC article.
The role of growth factor signaling in malignancy.
Herbst RS, Onn A, Mendelsohn J. Herbst RS, et al. Among authors: onn a. Cancer Treat Res. 2003;115:19-72. doi: 10.1007/0-306-48158-8_2. Cancer Treat Res. 2003. PMID: 12613192 Review. No abstract available.
New targets for the treatment of advanced non-small cell lung cancer.
Massarelli E, Onn A, Zinner R, Khuri FR, Kim ES, Herbst RS. Massarelli E, et al. Among authors: onn a. Cancer Chemother Biol Response Modif. 2002;20:717-61. Cancer Chemother Biol Response Modif. 2002. PMID: 12703232 Review. No abstract available.
Molecular targeted therapy for lung cancer.
Onn A, Herbst RS. Onn A, et al. Lancet. 2005 Oct 29-Nov 4;366(9496):1507-8. doi: 10.1016/S0140-6736(05)67608-8. Lancet. 2005. PMID: 16257327 No abstract available.
Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusion.
Massarelli E, Onn A, Marom EM, Alden CM, Liu DD, Tran HT, Mino B, Wistuba II, Faiz SA, Bashoura L, Eapen GA, Morice RC, Jack Lee J, Hong WK, Herbst RS, Jimenez CA. Massarelli E, et al. Among authors: onn a. Clin Lung Cancer. 2014 Sep;15(5):379-86. doi: 10.1016/j.cllc.2014.04.002. Epub 2014 May 14. Clin Lung Cancer. 2014. PMID: 24913066 Free PMC article. Clinical Trial.
124 results